Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.trecan.2021.05.004
Title: | Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises | Authors: | Pham, Melissa M Ngoi, Natalie YL Peng, Guang Tan, David SP Yap, Timothy A |
Issue Date: | Jun-2021 | Publisher: | Elsevier BV | Citation: | Pham, Melissa M, Ngoi, Natalie YL, Peng, Guang, Tan, David SP, Yap, Timothy A (2021-06). Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises. Trends in Cancer. ScholarBank@NUS Repository. https://doi.org/10.1016/j.trecan.2021.05.004 | Source Title: | Trends in Cancer | URI: | https://scholarbank.nus.edu.sg/handle/10635/194100 | ISSN: | 24058033 | DOI: | 10.1016/j.trecan.2021.05.004 |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Trends cancer pham.pdf | 689.17 kB | Adobe PDF | CLOSED | Published |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.